This article is part of the supplement: Proceedings of the Fifth International Society of Sports Nutrition (ISSN) Conference and Expo
Effects of Torabolic supplementation on strength and body composition during an 8-week resistance training program
-
* Corresponding author: Colin Wilborn cwilborn@umhb.edu
1 University of Mary Hardin-Baylor, Human Performance Lab, Belton, TX 76513, USA
2 The University of South Florida, Exercise and Performance Nutrition Lab, FL 33620, USA
3 Baylor University, Exercise and Biochemical Nutrition Lab, Waco TX, USA
4 Texas A&M University, Exercise and Sport Nutrition Lab, College Station, TX, USA
Journal of the International Society of Sports Nutrition 2008, 5(Suppl 1):P11 doi:10.1186/1550-2783-5-S1-P11
The electronic version of this article is the complete one and can be found online at: http://www.jissn.com/content/5/S1/P11
| Published: | 17 September 2008 |
© 2008 Wilborn et al; licensee BioMed Central Ltd.
Background
Torabolic is a highly purified unique molecule extracted from Fenugreek (Trigonella Foenun greacum) seeds. Torabolic is a proprietary patent pending molecule of Indus Biotech. The purpose of this study was to evaluate the effects of Torabolic supplementation on strength and body composition.
Methods
49 Resistance trained men were matched according to fat free mass and randomly assigned to ingest in a double blind manner capsules containing 500 mg of a placebo (N = 23, 20 ± 1.9 years, 178 ± 6.3 cm, 85 ± 12.7 kg, 17 ± 5.6 %BF) or TORABOLIC (N = 26, 21 ± 2.8 years, 178 ± 6 cm, 90 ± 18.2 kg, 19.3 ± 8.4 %BF). Subjects participated in a supervised 4-day per week periodized resistance-training program split into two upper and two lower extremity workouts per week for a total of 8-weeks. At 0, 4, and 8-weeks, subjects underwent hydrodensiometery body composition, 1 RM strength, muscle endurance, and anaerobic capacity determined. Data were analyzed using repeated measures ANOVA and are presented as mean ± SD changes from baseline after 60-days.
Results
No significant differences (p > 0.05) between groups were noted for training volume. Significant group × time interaction effects were observed among groups in changes in body fat (TOR: -2.3 ± 1.4%BF; PL: -0.39 ± 1.6 %BF, p < 0.001), leg press 1 RM (TOR: 84.6 ± 36.2 kg; PL: 48 ± 29.5 kg, p < 0.001), and bench press 1 RM (TOR: 9.1 ± 6.9 kg; PL: 4.3 ± 5.6 kg, p = 0.01). No significant interaction was observed among groups for Wingate power analysis (p = 0.95) or muscular endurance on bench press (p = 0.87) or leg press (p = 0.61). In addition there were no changes among groups in any clinical safety data including lipid panel, liver function, kidney function, and/or CBC panel (p > 0.05).
Conclusion
It is concluded that 500 mg of Torabolic supplementation had a significant impact on both upper- and lower body strength and body composition in comparison to placebo in a double blind controlled trial. These changes were obtained with no clinical side effects. We conclude that in addition to a structured resistance training program, Torabolic can significantly increase strength and muscle mass.
Acknowledgements
This study was sponsored by Indus Biotech.